Shamburg News · 8-K filed Nov 12, 2026, 4:41 PM EST

Rallybio Expects Avenzo Merger to Close November 20, 2026; Updates $13.90 Cash Distribution

RLYB · Rallybio Corp

  • Other event
  • Acquisition
  • Dividend
  • Stock split
  • Shareholder vote
  • Materiality: high

Rallybio Corporation announced that, subject to closing conditions, it anticipates the merger with Avenzo Therapeutics under the May 31, 2026 Merger Agreement will close following the close of trading on November 20, 2026, and received Nasdaq Capital Market listing approval for its common stock in connection with the merger. The company updated its previously announced special cash distribution of $13.90 per share, with a distribution record date of November 5, 2026, a payment date expected November 30, 2026, and due bill trading from the record date through November 20, 2026 ahead of a November 23, 2026 expected ex-dividend date. The filing also notes a reverse stock split expected to take effect November 20, 2026 and contingent value rights expected to be distributed November 23, 2026.

Read the filing on EDGAR ↗

Source: SEC EDGAR, Form 8-K, Item 8.01, accession 0001193125-26-458624.

Written from the filing by Shamburg Markets. Figures are as reported by the company.